Atazanavir versus lopinavir on Covid-19 infection: A retrospective protease inhibitors comparative study 2020.

导出 LinkOut

翻译打印收藏纠错

第一作者： Ahmad,Alikhani

第一单位： Department of Infectious Diseases, Antimicrobial Resistance Research Center and Communicable Disease Institute, Mazandaran University of Medical Sciences, Sari, Iran.

作者： Ahmad,Alikhani ^[1] ; Mobin,Ghazaiean ^[2] ; Roya,Ghasemian ^[1] ; Mohammad,Khademloo ^[3]

作者单位： Department of Infectious Diseases, Antimicrobial Resistance Research Center and Communicable Disease Institute, Mazandaran University of Medical Sciences, Sari, Iran. ^[1] School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran. ^[2] Department of Community Medicine, Mazandaran University of Medical Sciences, Sari, Iran. ^[3]

关键词 Atazanavir / ritonavir Covid-19 Efficacy Side effects lopinavir / ritonavir

DOI 10.22088/cjim.13.0.173

PMID 35872684

发布时间 2022-07-26

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Caspian journal of internal medicine

2022年13卷Suppl 3期

173-179页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Atazanavir versus lopinavir on Covid-19 infection: A retrospective protease inhibitors comparative study 2020.

Caspian journal of internal medicine

相似文献

Caspian journal of internal medicine

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Atazanavir versus lopinavir on Covid-19 infection: A retrospective protease inhibitors comparative study 2020.

Caspian journal of internal medicine

相似文献

Caspian journal of internal medicine

相关期刊

检索历史清除